In particular, CHI3L1 levels in the CSF were found to be significantly higher in active progressive MS compared with inactive progressive MS57,58, correlating with clinical and radiological disease activity in RRMS patients38,58, and predicting conversion from clinically isolated syndrome to MS59. This evidence concerns the gene CHI3L1 and myeloid sarcoma.